SGLT2 inhibitors and kidney outcomes trials

preview_player
Показать описание
Copyright Disclaimer under Section 107 of the copyright act 1976, allowance is made for fair use for purposes such as criticism, comment, news reporting, scholarship, and research. Fair use is a use permitted by copyright statute that might otherwise be infringing. Non-profit, educational or personal use tips the balance in favour of fair use.
  1. Paras Art Studio
Рекомендации по теме
SGLT2 Inhibitors in 0:09:06

SGLT2 Inhibitors in Chronic Kidney Disease

SGLT2 Inhibitors: Can 0:49:14

SGLT2 Inhibitors: Can these drugs slow the progression of chronic kidney disease?

Professor David Wheeler 0:35:24

Professor David Wheeler - 'How do SGLT2 inhibitors benefit the kidney?'

Benefits of SGLT2 0:06:11

Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists

How SGLT2 Inhibitors 0:16:24

How SGLT2 Inhibitors Protect The Kidney

SGLT2 inhibitors and 0:35:45

SGLT2 inhibitors and kidney outcomes trials | IDEC 2021

Improving Renal Outcomes 0:19:55

Improving Renal Outcomes With Glucose-Lowering Therapy in the Individualized Management of T2DM

Basic Mechanisms of 0:12:43

Basic Mechanisms of SGLT2 inhibitors in the Kidney

What are SGLT2 0:10:55

What are SGLT2 inhibitors and how do they affect kidney disease?

Professor David Wheeler 0:30:05

Professor David Wheeler - Renoprotective effects of SGLT2 inhibitors

Professor Christoph Wanner 0:26:36

Professor Christoph Wanner - Renoprotective effects of SGLT2 inhibitors

SGLT2 inhibitors and 0:35:45

SGLT2 inhibitors and kidney outcomes trials

Nephrology Grand Rounds: 0:58:38

Nephrology Grand Rounds: SGLT2 Inhibitors

CKD E-Learning - 0:46:01

CKD E-Learning - SGLT-2 inhibitors and CKD - 05.19.21

Assimilating the Evidence 0:02:59

Assimilating the Evidence in T2DM: Cardiovascular and Renal Outcomes With SGLT2 Inhibitors

Using SGLT2-inhibitors to 0:13:49

Using SGLT2-inhibitors to treat cardiac patients with diabetes

Evolving therapies to 0:59:34

Evolving therapies to treat chronic kidney disease - UBC and BCR Province Wide Rounds 10.28.2022

Part 6 - 0:02:49

Part 6 - Primary Care Insights from the KDIGO CKD Guideline: SGLT2 Inhibitors

DAPA-CKD: Renal benefits 0:08:14

DAPA-CKD: Renal benefits of SGLT2 inhibition in people with and without diabetes | Hiddo Heerspink

11-10-2022 - SGLT2i: 0:58:30

11-10-2022 - SGLT2i: Evidence and Mechanisms for a Nephrology-Cardiology Consensus

SGLT2 Inhibitors and 0:08:15

SGLT2 Inhibitors and Heart Failure

HOT TOPIC: Diabetic 0:47:18

HOT TOPIC: Diabetic Kidney Disease (DKD) – News You Should Know Now

SGLT2 Inhibitors & 1:23:07

SGLT2 Inhibitors & Cardiovascular Outcome

Professor Stephen Wiviott 0:34:54

Professor Stephen Wiviott - 'SGLT2 Outcome trials - an evolving story'